This bill authorizes an emergency appropriation of approximately $19.66 million to the Oklahoma Department of Mental Health and Substance Abuse Services. The funds must come from the Rate Preservation Fund in the State Treasury and are designated specifically for Title XIX services, which are Medicaid-funded mental health and substance abuse programs. The legislation includes an emergency provision, allowing the funding to take effect immediately upon the governor's approval without waiting for the regular budget cycle. This action provides direct financial resources to the state agency responsible for administering mental health and substance abuse services.
SB 2043 repeals Section 2-1101 of Oklahoma's Uniform Controlled Dangerous Substances Act, which previously provided legal protections for harm-reduction services. This change directly affects organizations and programs offering services like needle exchanges or overdose prevention, removing their statutory immunity. The bill also amends definitions in Sections 2-101 and 2-101.1 to update language about drug paraphernalia and eliminate related protections. It declares an emergency to take effect immediately upon enactment. This is a procedural legislative change removing existing legal safeguards for harm-reduction initiatives.
HB 3834, the "Oklahoma Breakthrough Therapy Act," establishes a framework for ibogaine clinical trials in Oklahoma. It requires drug developers to match state funding for trials, provide detailed plans for FDA approval and post-approval patient access (including priority for state residents and low-income care), and share intellectual property proceeds with the state. These proceeds fund an "Ibogaine Intellectual Property Account" managed by the State Treasurer, which must be spent on programs for at-risk populations with conditions treatable by ibogaine (like opioid use disorder). The bill also protects Oklahoma-licensed medical professionals from adverse licensing actions for recommending ibogaine therapy.
SB 1647 creates a revolving fund called the County Community Safety Investment Fund within Oklahoma's Department of Mental Health and Substance Abuse Services. The bill broadens the fund's purpose to support evidence-based county programs including mental health/substance abuse treatment, pretrial diversion, jail intake screenings, employment, education, and housing services. Counties and multi-county partnerships can apply for funding, while the Oklahoma Indigent Defense System Board may receive up to $1 million annually for similar programs. The bill requires annual reporting to state legislators on fund allocations and program outcomes. It becomes effective July 1, 2026, with an emergency declaration.
HB 4200 updates key definitions in Oklahoma's Mental Health Law to clarify eligibility for treatment and services. It revises the definition of "mental illness" to include specific impairments in thought, mood, or behavior, and adds detailed criteria for determining who qualifies as a "person requiring treatment" (e.g., immediate risk of self-harm or harm to others). The bill also specifies that certain conditions - like dementia, intellectual disabilities, homelessness, or seizure disorders - do not automatically qualify someone as needing treatment under this law. These changes directly affect mental health providers, courts, and patients by standardizing how treatment eligibility is assessed. The bill focuses solely on defining terms, not creating new programs or funding.
SB 1642 allows healthcare providers to issue initial opioid prescriptions for acute pain in "divided quantities" (e.g., splitting a seven-day supply into two parts to be filled on different dates), while still counting as a single prescription under the seven-day limit. It directly affects doctors and other prescribers who treat acute pain with opioids, requiring them to use immediate-release drugs at the lowest effective dose. Key provisions include mandating "do not fill until" dates for the second part of the divided prescription and requiring documentation of the rationale for splitting. The bill maintains existing requirements like seven-day limits, thorough patient consultations about opioid risks, and prescription monitoring checks.
HB 3795 ensures parents have full access to their minor child's medical records (including lab results, prescriptions, and electronic portal access) until the child turns 18, unless specific exceptions apply. Health care providers must grant this access within five business days without charging fees and cannot require minors to create separate accounts. Exceptions include records related to minor-consent services (like STI testing, substance abuse treatment, or pregnancy care), court-ordered restrictions, or documented risks of harm to the minor. Violations would be treated as deceptive practices under Oklahoma law.
HB 4362 requires the Oklahoma Health Care Authority to apply for a federal 1115 waiver to expand Medicaid coverage for medical respite care (short-term recovery support after hospital stays) and supportive housing (housing with health services). This bill directly affects Oklahoma Medicaid beneficiaries who need these specific services but currently lack coverage. The key provision mandates the state to seek federal approval for this expansion, which would allow more vulnerable residents to access these critical care options. The change would take effect on November 1, 2026, if the waiver is approved.
SB 1849 modifies Oklahoma's continuing education requirements for podiatrists renewing their licenses. It mandates 60 hours of continuing education every two years, including at least 2 hours on pain management, opioid use, or addiction (unless the practitioner lacks a federal DEA registration). The bill broadens acceptable continuing education to include medical marijuana training approved by the Board and allows out-of-state practitioners to substitute hours from where they practice. Fully retired podiatrists are exempt but must complete accrued requirements if they resume practice. The changes take effect November 1, 2026.
SB 2097 amends specific definitions within Oklahoma's Juvenile Code (10A O.S. 2021, Section 2-1-103) to clarify terminology used in juvenile justice proceedings. It defines key terms like "behavioral health" (including mental health and substance abuse treatment), "community-based" services (near-home programs for prevention/diversion), and "core community-based" services (specific counseling, case management, and rehabilitative treatments). The bill directly affects juveniles, families, and juvenile justice professionals by standardizing how services and legal terms are applied in court and treatment settings. This definition update aims to improve consistency in implementing existing juvenile justice programs and reporting.
